总时间（秒）：25.43
问答时间（秒）：25.20

```json
[
  {
    "variant": "",
    "context": "Context: Parkinson's disease associated protein parkin interacts with PINK1 in autophagy",
    "assay_class": "Protein interaction assay",
    "evidence": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "steps": [
      {
        "step": 1,
        "internal_question": "Does the paper clearly define the disease mechanism relevant to the functional assay being described for this variant?",
        "extracted_paper_info": "The study focuses on parkin and PINK1 proteins in Parkinson's disease and their role in autophagy.",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step": 2,
        "internal_question": "Does the general class of assay used for this variant (protein interaction assay) effectively model or reflect the disease pathogenesis/mechanism defined in Step 1?",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step": 3,
        "sub_step": 3a,
        "internal_question1": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
        "internal_judgment1": "Yes",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step": 3,
        "sub_step": 3c,
        "internal_question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls?",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Sub-step 4a"
      },
      {
        "step": 4,
        "sub_step": 4a,
        "internal_question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Sub-step 4c"
      },
      {
        "step": 4,
        "sub_step": 4c,
        "internal_information": "OddsPath calculated for the interaction between parkin and known pathogenic PINK1 variant is > 18.7",
        "internal_judgment": "NA",
        "next_step_or_outcome": "Assign evidence strength"
      },
      {
        "step": "Overall Conclusion",
        "overall_conclusion": "The interaction between parkin and PINK1 is significantly stronger for the pathogenic variant, with an OddsPath > 18.7, supporting a very strong pathogenic effect."
      }
    ]
  },
  {
    "variant": "",
    "context": "Context: Parkinson's disease associated protein parkin interacts with PINK1 in autophagy",
    "assay_class": "Protein interaction assay",
    "evidence": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "steps": [
      {
        "step": 1,
        "internal_question": "Does the paper clearly define the disease mechanism relevant to the functional assay being described for this variant?",
        "extracted_paper_info": "The study focuses on parkin and PINK1 proteins in Parkinson's disease and their role in autophagy.",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step": 2,
        "internal_question": "Does the general class of assay used for this variant (protein interaction assay) effectively model or reflect the disease pathogenesis/mechanism defined in Step 1?",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step": 3,
        "sub_step": 3a,
        "internal_question1": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
        "internal_judgment1": "Yes",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step": 3,
        "sub_step": 3c,
        "internal_question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls?",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Sub-step 4a"
      },
      {
        "step": 4,
        "sub_step": 4a,
        "internal_question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Sub-step 4c"
      },
      {
        "step": 4,
        "sub_step": 4c,
        "internal_information": "OddsPath calculated for the interaction between parkin and known pathogenic PINK1 variant is > 2.0 and <= 4.3",
        "internal_judgment": "NA",
        "next_step_or_outcome": "Assign evidence strength"
      },
      {
        "step": "Overall Conclusion",
        "overall_conclusion": "The interaction between parkin and PINK1 is significantly stronger for the pathogenic variant, with an OddsPath > 2.0 but <= 4.3, supporting a pathogenic effect."
      }
    ]
  },
  {
    "variant": "",
    "context": "Context: Parkinson's disease associated protein parkin interacts with PINK1 in autophagy",
    "assay_class": "Protein interaction assay",
    "evidence": {
      "type": "Benign",
      "strength": "BS3_supporting"
    },
    "steps": [
      {
        "step": 1,
        "internal_question": "Does the paper clearly define the disease mechanism relevant to the functional assay being described for this variant?",
        "extracted_paper_info": "The study focuses on parkin and PINK1 proteins in Parkinson's disease and their role in autophagy.",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step": 2,
        "internal_question": "Does the general class of assay used for this variant (protein interaction assay) effectively model or reflect the disease pathogenesis/mechanism defined in Step 1?",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step": 3,
        "sub_step": 3a,
        "internal_question1": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
        "internal_judgment1": "Yes",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step": 3,
        "sub_step": 3c,
        "internal_question": "Were variant controls used in the assay for this variant? Specifically, were known benign variants used as controls?",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Sub-step 4a"
      },
      {
        "step": 4,
        "sub_step": 4a,
        "internal_question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
        "internal_judgment": "Yes",
        "next_step_or_outcome": "Proceed to Sub-step 4c"
      },
      {
        "step": 4,
        "sub_step": 4c,
        "internal_information": "OddsPath calculated for the interaction between parkin and known benign PINK1 variant is < 2.0",
        "internal_judgment": "NA",
        "next_step_or_outcome": "Assign evidence strength"
      },
      {
        "step": "Overall Conclusion",
        "overall_conclusion": "The interaction between parkin and PINK1 is significantly weaker for the benign variant, with an OddsPath < 2.0, supporting a benign effect."
      }
    ]
  }
]
```